Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10

BIOLOGICAL2 trials

Sponsors

Fred Hutchinson Cancer Center

Conditions

Multiple MyelomaPlasma Cell MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma

Phase 1

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

WithdrawnNCT04466475

Fred Hutchinson Cancer CenterPlasma Cell Myeloma

Start: 2024-01-27End: 2027-09-30Updated: 2024-01-31

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

WithdrawnNCT04579523

Fred Hutchinson Cancer CenterMultiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma

Start: 2027-06-01End: 2029-12-31Updated: 2026-09-11